Eisai Cuts Profit Forecast, Predicts Drop

Eisai Cuts Profit Forecast, Predicts Drop

Tomohiro Ohsumi/Bloomberg News

Revenue from Aricept, once the world’s best-selling medicine for Alzheimer’s disease, plunged 50 percent to 123.4 billion yen in the nine months ended Dec. 31.